Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

References for PMC Articles for PubMed (Select 15817760)

1.
2.

Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.

Wyatt LS, Earl PL, Eller LA, Moss B.

Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4590-5. Epub 2004 Mar 11.

3.

Cutting edge: long-term B cell memory in humans after smallpox vaccination.

Crotty S, Felgner P, Davies H, Glidewell J, Villarreal L, Ahmed R.

J Immunol. 2003 Nov 15;171(10):4969-73.

4.
5.

Duration of antiviral immunity after smallpox vaccination.

Hammarlund E, Lewis MW, Hansen SG, Strelow LI, Nelson JA, Sexton GJ, Hanifin JM, Slifka MK.

Nat Med. 2003 Sep;9(9):1131-7. Epub 2003 Aug 17.

6.

Smallpox vaccination in 2003: key information for clinicians.

Bartlett J, Borio L, Radonovich L, Mair JS, O'Toole T, Mair M, Halsey N, Grow R, Inglesby TV.

Clin Infect Dis. 2003 Apr 1;36(7):883-902. Epub 2003 Mar 18. No abstract available.

7.

A model for a smallpox-vaccination policy.

Bozzette SA, Boer R, Bhatnagar V, Brower JL, Keeler EB, Morton SC, Stoto MA.

N Engl J Med. 2003 Jan 30;348(5):416-25. Epub 2002 Dec 19.

8.
9.

Studies in smallpox and vaccination. 1913.

Hanna W, Baxby D.

Rev Med Virol. 2002 Jul-Aug;12(4):201-9. No abstract available.

PMID:
12125012
10.

Smallpox: anything to declare?

Smith GL, McFadden G.

Nat Rev Immunol. 2002 Jul;2(7):521-7.

PMID:
12094226
11.

Modeling potential responses to smallpox as a bioterrorist weapon.

Meltzer MI, Damon I, LeDuc JW, Millar JD.

Emerg Infect Dis. 2001 Nov-Dec;7(6):959-69.

12.

Bioterrorism. Smallpox vaccinations: how much protection remains?

Cohen J.

Science. 2001 Nov 2;294(5544):985. No abstract available.

PMID:
11691969
13.

Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

Henderson DA, Inglesby TV, Bartlett JG, Ascher MS, Eitzen E, Jahrling PB, Hauer J, Layton M, McDade J, Osterholm MT, O'Toole T, Parker G, Perl T, Russell PK, Tonat K.

JAMA. 1999 Jun 9;281(22):2127-37. Review.

PMID:
10367824
14.

Human cytotoxic T-cell memory: long-lived responses to vaccinia virus.

Demkowicz WE Jr, Littaua RA, Wang J, Ennis FA.

J Virol. 1996 Apr;70(4):2627-31.

15.

The meaning and use of the area under a receiver operating characteristic (ROC) curve.

Hanley JA, McNeil BJ.

Radiology. 1982 Apr;143(1):29-36.

PMID:
7063747
16.

Selection and interpretation of diagnostic tests and procedures. Principles and applications.

Griner PF, Mayewski RJ, Mushlin AI, Greenland P.

Ann Intern Med. 1981 Apr;94(4 Pt 2):557-92. No abstract available.

PMID:
6452080
17.

A prospective study of serum antibody and protection against smallpox.

Mack TM, Noble J Jr, Thomas DB.

Am J Trop Med Hyg. 1972 Mar;21(2):214-8. No abstract available.

PMID:
5061278
18.

Smallpox in Europe, 1950-1971.

Mack TM.

J Infect Dis. 1972 Feb;125(2):161-9. No abstract available.

PMID:
5007552
19.

WHO Expert Committee on Smallpox Eradication. Second report.

[No authors listed]

World Health Organ Tech Rep Ser. 1972;493:1-64. No abstract available.

PMID:
4623268
20.

The persistence of neutralizing antibodies after revaccination against smallpox.

el-Ad B, Roth Y, Winder A, Tochner Z, Lublin-Tennenbaum T, Katz E, Schwartz T.

J Infect Dis. 1990 Mar;161(3):446-8.

PMID:
2155973
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk